Our Mission: to help people understand, access, and benefit from their epigenome. We also research & develop epigenetic analysis methods in the effort to create new methylation-based medical diagnostic tools.
Our Core Values:
TruDiagnostic is built by scientists, so all of our decisions are made with real evidence and real research. We only ever use proven processes and are committed to the high standards that allow us to be a trusted source of epigenetic information.
Creating the Rosetta Stone of epigenetic information & health
We want to revolutionize the Health and Aging industry.
Biological Aging is only the first step. We've leveraged data generated in the largest private epigneetic databae in the world to create tools that look at specific methylation to detect changing disease risk. We're already running clinical trials with products that claim to reduce aging, to see if they’re really as effective as they say they are.
We’re working with universities and top scientists from around the world to create new methods of epigenetic identification, new algorithms, and expanding what was once an epigenetic testing lab into a full multi-omic suite.
We want to deliver the most accurate, most comprehensive epigenetic analysis that we can, without compromise.
Epigenetics is still a pretty new field. ‘Health’ and ‘Aging’ are used as buzzwords for a lot of pseudoscience, but they’re also real and important concepts in the human effort to lengthen our lifespans and improve long-term quality of life. We want to help educate the public about how habits and choices can change you at the epigenetic level, and how people have more control over their own general health than they assume.
The wellbeing of our company depends on the wellbeing of our employees. We support each other, and learn from each other’s diverse experiences. We want to foster a positive, collaborative environment with plenty of opportunity to grow.
THOUGHT LEADERS & ADVISORY BOARD
Dr. Lasky-Su is an Associate Professor in Medicine and Associate Statistician and Epidemiologist
at Harvard Medical School and Brigham and Women’s Hospital. Dr. Lasky-Su has focused on the analysis of genetics, genomics, and metabolomics data in large scale human studies,
Dr. Daniel L. Stickler is the Co-Founder and Chief Medical Officer at Apeiron ZOH Inc. He is also the Medical Director for the Neurohacker Collective
Dr. David Haase serves as medical advisor to Evoke Neuroscience – a company that delivers technologies that promote brain health, and Metabolon – which develops metabolomics diagnostics for precision medicine.
Dr. Dominique Fradin-Read is board certified in Preventive Medicine. She is also a Fellow of the American Academy of Anti-Aging Medicine. She now holds an appointment as Assistant Clinical Professor at the Loma Linda University School of Medicine.
Dr. Gregory Hannum developed one of the first Epigenetic Clocks. He received his Ph.D in Bioengineering from the University of California. He is an author of more than 16 publications and 4 patents.